Hence, diagnostic tools for non-Aβ-Tau biomarkers as advanced reporters in cooperation with Aβ and Tau detection are essential to enable the early diagnosis, accurate observation of progression and therapeutic effects of AD. The gene discussed is MAPT; the disease is Alzheimer disease.